Discussion in 'Other Health News and Research' started by Indigophoton, Nov 3, 2017.
Good news for patients in the UK:
If rituximab comes up good, then...
I heard this mentioned on this morning's news and I think that part of the mechanism of fast-tracking was to run in parallel the assessments that are usually done in sequence.
Government as designed by a computer scientist.
Guess who will be at the bottom of the list every time. Sorry, we've done our 5 for this year...
I don't know though - if something genuinely useful comes along (rituximab or whatever), then the fact that there is nothing at all for ME at the moment might help us to be prioritised.
Plus, those with ME who are economically inactive must be costing the country a bit, so it could be very cost-effective to get us back on our feet
Separate names with a comma.